Skip to content

Modified T-Stenting With Szabo Technique Versus T-Stenting for Bifurcation Lesions in Coronary Heart Diseases

Modified T-Stenting With Szabo Technique Versus T-Stenting for Bifurcation Lesions in Coronary Heart Diseases: SZABO Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03714802
Enrollment
100
Registered
2018-10-22
Start date
2019-01-01
Completion date
2024-12-31
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

bifurcation lesion, percutaneous coronary intervention, Szabo, T-stenting

Brief summary

The study will compare clinical outcomes of modified T-stenting with Szabo technique with T-stenting for bifurcation lesions in coronary heart diseases.

Detailed description

Accurate deployment of stents in ostial lesions is difficult with traditional angiographic guidance. Szabo technique, which used a second angioplasty guide wire to anchor the stent by passing the proximal end of the anchor wire through the last cell of the stent, demonstrated accurate placement of the stents in ostial locations. In bifurcation lesions, 2-stent strategy positioning with Szabo technique was not investigated. Modified T-stenting with Szabo technique may improve prognosis of bifurcation lesions through reducing stents overlap. There is no clinical trial focuses on the effect and outcome of Szabo technique for coronary artery bifurcation lesions in contrast with conventional strategy. In this study, the authors choose the closest 2-stent strategy, T-stenting, as control. We hope to determine whether a planned Szabo 2-stent technique is superior to T-stenting for patients with bifurcation lesions. Patients with bifurcation lesions will be randomly assigned to receive Szabo 2-stent technique or T-stenting strategy. Clinical outcomes and imaging assessment will be used to estimate their effects.

Interventions

PROCEDURESzabo T-Stenting Technique

2-stent strategy was performed using modified T-stenting with Szabo technique in bifurcation lesions. First, stent was implanted in the side branch with Szabo technique. Then, stent was implanted in the main branch. Finally, kissing balloon inflation was performed.

PROCEDURET-Stenting Technique

2-stent strategy was performed using traditional T-stenting technique in bifurcation lesions. First, stent was implanted in the side branch with angiographic guidance. Then, stent was implanted in the main branch. Finally, kissing balloon inflation was performed.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patient must be at least ≥18 years of age. * Lesions are eligible for percutaneous coronary intervention (PCI). * Patient has stable/unstable angina or myocardial infarction (MI). * Bifurcation lesions (Medina 1,1,1/0,1,1/1,0,1) without left main ostial lesions. * Downstream lesions could be covered by two stents. * Diameter of vessel ≥2.25mm * Diameter stenosis in main vessel and side branch ≥ 50% by visual estimation.

Exclusion criteria

* Severe tortuosity or calcification affected procedural success. * Patient was allergic to the study stent or protocol-required concomitant medications. * Patient is intolerable to dual anti-platelet therapy. * Patient has any other serious medical illness that may reduce life expectancy to\<12 months. * Patient is a woman who is pregnant or nursing. * Patient has a planned procedure that may cause non-compliance with the protocol or confound data interpretation. * Patient is participating in another clinical trial that has not reached its primary endpoint within 24 months after the index procedure. * Coronary restenosis.

Design outcomes

Primary

MeasureTime frameDescription
Composite of cardiac death, nonfatal myocardial infarction and target lesion revascularization1 year after coronary angiographyrecord in follow-up

Secondary

MeasureTime frameDescription
rate of cardiac death rate30 days and 12 months after primary angiographyRecorded in follow-up
rate of recurrent myocardial infarction rate30 days and 12 months after primary angiographyRecorded in follow-up
rate of target vessel revascularization rate30 days and 12 months after primary angiographyRecorded in follow-up
rate of all cause death30 days and 12 months after primary angiographyRecorded in follow-up
residual stenosis degreeImmediately after stent implantation and 12 months after primary angiographyMeasured through intravenous ultrasound
residual stenosis of side branchImmediately after stent implantation and 12 months after primary angiographyMeasured through angiography
late lumen lossindex procedure and 12 months follow upMeasured through intravenous ultrasound
rate of stent thrombosis30 days and 12 months after primary angiographyRecorded in follow-up

Countries

China

Contacts

Primary ContactHongbo Yang, M.D.
yang.hongbo@zs-hospital.sh.cn008613585890793
Backup ContactZheyong Huang, M.D.
huang.zheyong@zs-hospital.sh.cn008613512100180

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026